Wendy's/Arby's, BioLase: Small-Cap Winners

NEW YORK ( TheStreet) -- Wendy's/Arby's ( WEN) was a prominent gainer in the small-cap space Thursday, after the Atlanta-based restaurant opeartor said that it was considering a sale of its roast-beef sandwich chain Arby's to focus on its hamburger business.

Arby's constitutes about 30% of its revenues, but has been struggling in the recession and has been a drag on total sales.

Shares were up 8.5% to $4.85. Trading volumes jumped to over 12 million in afternoon trading.

The real winner on Thursday's trading so far is dental laser company BioLase Technology ( BLTI), soaring a whopping 90% to $3.21, a 52-week high, after it said that it expects to see a profit in the fourth quarter after three quarters of loss.

The company issued annual revenue guidance for 2011 in the range of $55 million to $60 million, representing a growth of approximately 120 percent to 140 percent over 2010. Net revenue for the first quarter ended March 31 is expected to range between $8.75 million to $9.25 million, up from $4.4 million in the first quarter of 2010.

Over 4 million shares traded hands on Thursday. Average volume in the last three months has ranged in the low 50,000.

Shares of Rexahn Pharmaceuticals ( RNN), a clinical stage pharmaceutical company engaged in oncology and the nervous system, was shooting up 9.8% to $1.34. The company announced that Israel-based Teva Pharmaceuticals ( TEVA) had purchased a 6.3% stake in the company, picking up 2.3 million shares in a private offering at $1.692 per share.

The investment money will be used for the purpose of supporting the research and development program for the preclinical stage, anti-cancer compound RX-3117.

Trading company Knight Capital ( KCG) was gaining 6% to $14.02 after it beat expectations on revenues, even though it disappointed on earnings. Revenues from continuing operations for the fourth quarter of 2010 were $259.0 million, compared to $303.3 million from continuing operations for the fourth quarter of 2009. Still, it was higher than analyst estimates of $254 million.

Shares of PDL BioPharma ( PDLI) surged 3.4% to $5.12 after RBC Capital upgraded it to outperform with a price target of $6.

GT Solar ( SOLR) saw its shares rise 2% to $10.96 after it nabbed a $33.3 million LED deal from South Korean polysilicon giant OCI.

Office Depot ( ODP), Dean Foods ( DF), JetBlue Airways ( JBLU) and Corinithian Colleges ( COCO) were also gaining on higher volumes.

-- Written by Shanthi Bharatwaj in New York

>To contact the writer of this article, click here: Shanthi Bharatwaj.

>To follow the writer on Twitter, go to http://twitter.com/shavenk.

>To submit a news tip, send an email to: tips@thestreet.com.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

More from Investing

GE's $11.1 Billion Deal With Wabtec Should Have Warren Buffett Feeling Very Sad

GE's $11.1 Billion Deal With Wabtec Should Have Warren Buffett Feeling Very Sad

How Technology Will Unleash the Legal Marijuana Industry's Growth Potential

How Technology Will Unleash the Legal Marijuana Industry's Growth Potential

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

The Stock Market Has Every Reason to See a Fresh Rally

The Stock Market Has Every Reason to See a Fresh Rally

18 Top Stocks Hedge Funds Own That Goldman Sachs Thinks Will Keep Outperforming

18 Top Stocks Hedge Funds Own That Goldman Sachs Thinks Will Keep Outperforming